Inventor · disambiguated record
Jeonghoon Sun
Also filed as: SUN JEONGHOON
38 granted patents·21 pending applications·869 citations·filing 2007–2025
98Inventor score
Top patents by PatentIndex Score
59 records- 0198US8999917B2Variant activin receptor polypeptides and uses thereofAMGEN INC·Filed 2013·Granted Apr 7, 2015·48 cites·19 claims
- 0298US8642546B2FGF21 mutant fusion polypeptides and uses thereofBELOUSKI EDWARD JOHN·Filed 2011·Granted Feb 4, 2014·64 cites·11 claims
- 0398US8410051B2FGF21 mutants and uses thereofBELOUSKI EDWARD JOHN·Filed 2011·Granted Apr 2, 2013·63 cites·21 claims
- 0498US8361963B2Uses of FGF21 polypeptides comprising two or more mutationsAMGEN INC·Filed 2011·Granted Jan 29, 2013·64 cites·4 claims
- 0598US8034770B2FGF21 polypeptides comprising two or more mutationsAMGEN INC·Filed 2009·Granted Oct 11, 2011·63 cites·15 claims
- 0697US8835385B2FGF21 polypeptides comprising two or more mutations and uses thereofBELOUSKI EDWARD JOHN·Filed 2012·Granted Sep 16, 2014·48 cites·26 claims
- 0797US8795985B2FGF 21 polypeptides comprising two or more mutations and uses thereofBELOUSKI EDWARD JOHN·Filed 2012·Granted Aug 5, 2014·48 cites·18 claims
- 0897US8618053B2FGF21 mutants multimers and uses thereofBELOUSKI EDWARD JOHN·Filed 2012·Granted Dec 31, 2013·45 cites·18 claims
- 0997US8188040B2FGF21 mutants and uses thereofBELOUSKI EDWARD JOHN·Filed 2010·Granted May 29, 2012·59 cites·21 claims
- 1097US7947646B2Variant activin receptor polypeptidesAMGEN INC·Filed 2008·Granted May 24, 2011·66 cites·24 claims
- 1196US9809638B2Variant activin receptorAMGEN INC·Filed 2016·Granted Nov 7, 2017·25 cites·20 claims
- 1296US8716459B2Isolated nucleic acid molecules encoding variant activin receptor polypeptidesSUN JEONGHOON·Filed 2011·Granted May 6, 2014·48 cites·32 claims
- 1396US8410043B2Stabilized activin IIB receptor polypeptides and uses thereofSUN JEONGHOON·Filed 2009·Granted Apr 2, 2013·54 cites·15 claims
- 1495US8501678B2Variant activin receptor polypeptides and uses thereofSUN JEONGHOON·Filed 2011·Granted Aug 6, 2013·38 cites·20 claims
- 1594US9273114B2Stabilized receptor polypeptides and uses thereofAMGEN·Filed 2013·Granted Mar 1, 2016·19 cites·31 claims
- 1694US9273106B2FGF mutants with reduced proteolysis and aggregationAMGEN INC·Filed 2013·Granted Mar 1, 2016·9 cites·21 claims
- 1793US11072640B2Methods of treating non-alcoholic steatohepatitis using FGF21 mutantsAMGEN INC·Filed 2018·Granted Jul 27, 2021·3 cites·12 claims
- 1893US10407487B2Variant activin receptorAMGEN INC·Filed 2017·Granted Sep 10, 2019·11 cites·20 claims
- 1993US10308704B2Isolated nucleic acid molecules encoding stabilized receptor polypeptides and uses thereofAMGEN INC·Filed 2016·Granted Jun 4, 2019·12 cites·8 claims
- 2093US10011642B2Methods of treating of diabetes and obesity using FGF21 mutantsAMGEN INC·Filed 2016·Granted Jul 3, 2018·4 cites·28 claims
- 2191US9447165B2Variant activin IIB receptorAMGEN INC·Filed 2014·Granted Sep 20, 2016·11 cites·20 claims
- 2291US2025136653A1FGF21 Mutants and Uses ThereofAMGEN INC·Filed 2024·Application pending·0 cites
- 2390US2024076333A1FGF21 Mutants and Uses ThereofAMGEN INC·Filed 2023·Application pending·0 cites
- 2489US11667699B2Anti-MS4A4A antibodies and methods of use thereofALECTOR LLC·Filed 2020·Granted Jun 6, 2023·3 cites·93 claims
- 2588US10428145B2PD-1 binding proteins and methods of use thereofCELGENE CORP·Filed 2016·Granted Oct 1, 2019·10 cites·155 claims
- 2688US9493530B2FGF21 mutants comprising a mutation at position 98, 171 and/or 180AMGEN INC·Filed 2014·Granted Nov 15, 2016·10 cites·25 claims
- 2787US9610327B2Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereofAMGEN INC·Filed 2012·Granted Apr 4, 2017·11 cites·19 claims
- 2885US8541201B2Thrombopoietic compoundsMIN HOSUNG·Filed 2011·Granted Sep 24, 2013·9 cites·4 claims
- 2984US9517264B2Human FGF receptor and β-Klotho binding proteinsFACHINI ROGER·Filed 2011·Granted Dec 13, 2016·19 cites·41 claims
- 3084US2023295267A1Stabilized receptor polypeptides and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 3180US11840558B2Methods of treating non-alcoholic steatohepatitis using FGF21 mutantsAMGEN INC·Filed 2021·Granted Dec 12, 2023·0 cites·23 claims
- 3279US2024010708A1Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methodsAMGEN INC·Filed 2023·Application pending·0 cites
- 3377US7981425B2Thrombopoietic compoundsAMGEN INC·Filed 2007·Granted Jul 19, 2011·2 cites·1 claims
- 3474US9688756B2Variant Fc-polypeptides with enhanced binding to the neonatal Fc receptorAMGEN INC·Filed 2012·Granted Jun 27, 2017·3 cites·16 claims
- 3572US11685770B2Stabilized receptor polypeptides and uses thereofAMGEN INC·Filed 2019·Granted Jun 27, 2023·0 cites·6 claims
- 3670US2024279305A1SIGLEC-9 ECD Fusion Molecules and Methods of Use ThereofALECTOR LLC·Filed 2024·Application pending·0 cites
- 3770US2023272076A1PD-1 Binding Proteins and Methods of Use ThereofCELGENE CORP·Filed 2022·Application pending·0 cites
- 3867US2025346662A1Homogeneous antibody populationsAMGEN INC·Filed 2025·Application pending·0 cites
- 3967US2024383997A1Proteins comprising blood brain barrier (bbb)-binding domains within constant domainsALECTOR LLC·Filed 2024·Application pending·0 cites
- 4066US2024076362A1Anti-ms4a4a antibodies and methods of use thereofALECTOR LLC·Filed 2023·Application pending·0 cites
- 4165US2024075133A1Methods and compositions for reduction of immunogenicityCELGENE CORP·Filed 2023·Application pending·0 cites
- 4263US11987612B2Siglec-9 ECD fusion moleculesALECTOR LLC·Filed 2020·Granted May 21, 2024·0 cites·20 claims
- 4363US10189890B2Variants of tissue inhibitor of metalloproteinase type three (TIMP-3), compositions and methodsAMGEN INC·Filed 2014·Granted Jan 29, 2019·0 cites·6 claims
- 4462US2022324991A1Bcma-binding antibodies and uses thereofCELGENE CORP·Filed 2022·Application pending·0 cites
- 4561US2020255525A1Pd-1 binding proteins and methods of use thereofCELGENE CORP·Filed 2019·Application pending·0 cites
- 4659US12428488B2Engineering of an antibody for tumor-selective binding of CD47CELGENE CORP·Filed 2020·Granted Sep 30, 2025·0 cites·17 claims
- 4759US2010226925A1Homogeneous Antibody PopulationsAMGEN INC·Filed 2008·Application pending·0 cites
- 4857US12084499B2SIRP-α binding proteins and methods of use thereofCELGENE CORP·Filed 2023·Granted Sep 10, 2024·0 cites·31 claims
- 4957US2019085054A1Variants of tissue inhibitor of metalloproteinase type three (timp-3), compositions and methodsAMGEN INC·Filed 2018·Application pending·0 cites
- 5057US2015231206A1Variant activin receptor polypeptides and uses thereofAMGEN INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jeonghoon Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →